Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Clearwire Closes $1.5B, Alder Scores $1B Partnership, Software Financings Are Down, & More Seattle-Area Deals News
|
Gregory T. Huang |
11/10/09 |
Seattle
|
|
Verathon, Maker of Diagnostic Ultrasound Tools, Acquired by Roper as Part of $356M Deal
|
Luke Timmerman |
11/09/09 |
Seattle
|
|
SonoSite Sales Drop 13%
|
Luke Timmerman |
10/27/09 |
Seattle
|
|
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/22/09 |
Seattle
|
|
Sonosite Gets $21M From GE
|
Luke Timmerman |
10/19/09 |
Seattle
|
|
Medical Device Startups Getting Squeezed by Recession, Lawmakers, Says E&Y Report
|
Luke Timmerman |
10/13/09 |
National
|
|
Top 10 Lessons in Starting Companies and Commercializing Technologies, from UW Panel
|
Eric Hal Schwartz |
08/03/09 |
Seattle
|
|
Dendreon’s Former Boss Predicts Takeover, Covance Buys Merck Lab, How NanoString Got $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/30/09 |
Seattle
|
|
SonoSite Sales Dip 12 Percent
|
Luke Timmerman |
07/27/09 |
Seattle
|
|
Stem Cell Entrepreneur Quinn Dies, Dendreon Tames Shorts, PhysioSonics Monitors Brain Blood, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/02/09 |
Seattle
|
|
Yapta Closes Series B, PhysioSonics Scores $2M More, Powerit Talks Strategy, & More Seattle-Area Deals News
|
Gregory T. Huang |
06/30/09 |
Seattle
|
|
PhysioSonics, Looking at Blood in the Brain, Aims to Monitor Effects of Drugs
|
Luke Timmerman |
06/29/09 |
Seattle
|
|
PhysioSonics Nabs $2M
|
Luke Timmerman |
06/25/09 |
Seattle
|
|
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News
|
Luke Timmerman |
06/25/09 |
Seattle
|
|
Mirabilis Medica Aims to Help Women Avoid the Dreaded Hysterectomy
|
Luke Timmerman |
06/22/09 |
Seattle
|
|
SonoSite Buys CardioDynamics for $12.3M
|
Eric Hal Schwartz |
06/09/09 |
Seattle
|
|
SonoSite Lowers Sales Forecast
|
Luke Timmerman |
04/27/09 |
Seattle
|
|
Dendreon Saga Nears Climax, Gregoire Biotech Fund in Jeopardy, UW’s Biofuel Futurist, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/09/09 |
Seattle
|
|
SonoSite Revenue Dips
|
Luke Timmerman |
04/06/09 |
Seattle
|
|
Seattle-Area Company Closures: Sotto, TeachFirst, and Ultreo Shut Down
|
Gregory T. Huang |
03/12/09 |
Seattle
|
|
ImaRx’s Ultrasound Stroke Treatment, After Devastating Setback, Beats Clot-Busting Drug in Study
|
Luke Timmerman |
02/19/09 |
Seattle
|
|
Auth, O’Donnell Join Academy
|
Luke Timmerman |
02/09/09 |
Seattle
|
|
Pathway Medical Gets Traction, Ekos Raises $12.5M, ZymoGenetics Sales Boss Departs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
02/05/09 |
Seattle
|
|
Lenovo Buys Switchbox, Ekos Raises $12.5M, nLight Lands $10.7M, & More Seattle-Area Deals News
|
Gregory T. Huang |
02/03/09 |
Seattle
|
|
Ekos, Maker of Ultrasound Clot Dissolver, Raises $12.5 Million for Commercial Push
|
Luke Timmerman |
01/30/09 |
Seattle
|
|
Dendreon Expects Results in April, Seattle Genetics Plans Hodgkin’s Trial, ImaRx Moves to Town & More Seattle-Area Life Sciences News
|
Luke Timmerman |
01/22/09 |
Seattle
|
|
ImaRx, Led by Former Icos Manager, Comes to Town
|
Luke Timmerman |
01/20/09 |
Seattle
|
|
SonoSite Revenue Climbs 19 Percent
|
Luke Timmerman |
01/12/09 |
Seattle
|
|
Breast Cancer’s Hidden Side Effect: ImpediMed Aims to Spot Slow-Emerging Lymph Disorder
|
Luke Timmerman |
01/09/09 |
San Diego
|
|
Tysabri’s Roots at the “Hutch,” MediQuest Spurned by FDA, ZymoGenetics Drug Passes Test, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/06/08 |
Seattle
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
